Anaptysbio Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Anaptysbio Inc with three other
companies in this sector in the United States:
Harpoon Therapeutics Inc
sales of $4.75 million
of which 100%
was Biological Products),
Jaguar Health Inc
of which 97%
was Cancer Immunotherapy).
During the year ended December of 2018, sales at
Anaptysbio Inc were $5.00 million.
decrease of 50.0%
versus 2017, when the company's sales were $10.00 million.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Anaptysbio Inc had sales
of $5.48 million.